மையம் க்கு இனப்பெருக்கம் ஆரோக்கியம் News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Cheap Covid drug could combat heavy periods, study suggests
wimbledonguardian.co.uk - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from wimbledonguardian.co.uk Daily Mail and Mail on Sunday newspapers.
Cheap Covid drug could combat heavy periods
bristolpost.co.uk - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from bristolpost.co.uk Daily Mail and Mail on Sunday newspapers.
£5 Covid drug dexamethasone could combat heavy periods for millions of women, study claims
dailymail.co.uk - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from dailymail.co.uk Daily Mail and Mail on Sunday newspapers.
Cheap Covid drug could combat heavy periods - Nottinghamshire Live
nottinghampost.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from nottinghampost.com Daily Mail and Mail on Sunday newspapers.
(0)
Follow-on investment, led by Epidarex Capital, closes at £4.24m, following initial £3.2m Seed round in 2020; Caribou Property joins as new investor
Management appointments expand leadership team: Dr Steve Myatt, ex Azeria Therapeutics, to Chief Executive Officer; Dr Carola Ries, ex Roche, to Chief Scientific Officer; Co-founder Dr Luca Cassetta to move from his academic role at Edinburgh University to join as full-time VP Immunology
Funds will accelerate macrophage-based therapeutics R&D portfolio and target discovery capability; expansion of facilities in Edinburgh and Cambridge
Macomics Ltd, an immuno-oncology company with world-leading expertise in macrophage biology, announces today that it has closed a follow-on financing of £4.24 million from its 2020 Seed round, bringing the total amount raised to £7.44m.